May 15, 2024 / 08:30PM GMT
Operator
Good afternoon, everyone, and welcome to the Aytu Biopharma fiscal 2024 third-quarter earnings call. At this time, all participants have been placed in a listen-only mode. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Roger Weiss. Sir, the floor is yours.
Roger Weiss - Lytham Partners IR - Moderator
Good afternoon, everyone, and thank you for joining us for Aytu Biopharma's fiscal 2024 third-quarter financial and operational results conference call for the period ended March 31, 2024. Joining us in today's call is Aytu's CEO, Josh Disbrow; and the company's Chief Financial Officer, Mark Oki. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session. I'd like to remind everyone that today's call is being recorded.
A replay of today's call will be available by using the telephone numbers and conference ID provided in the press release issued earlier today. Finally, I'd like to call your attention to the customary safe harbor disclosure regarding forward-looking information.
Q3 2024 Aytu Biopharma Inc Earnings Call Transcript
May 16, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers